Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP930077.RAQXdqDcDCINCznM6jqz_BWdeZ9vzRAtDhGSfun8TJn_0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP930077.RAQXdqDcDCINCznM6jqz_BWdeZ9vzRAtDhGSfun8TJn_0130_assertion type Assertion NP930077.RAQXdqDcDCINCznM6jqz_BWdeZ9vzRAtDhGSfun8TJn_0130_head.
- NP930077.RAQXdqDcDCINCznM6jqz_BWdeZ9vzRAtDhGSfun8TJn_0130_assertion description "[Inhibition of neointimal hyperplasia may also be achieved by gene transfer of endothelial NO synthase (eNOS), PGI synthase, or cell cycle regulators (retinoblastoma, cyclin or cyclin-dependent kinase inhibitors, p53, growth arrest homeobox gene, fas ligand) or antisense oligonucleotides to c-myb, c-myc, proliferating cell nuclear antigen, and transcription factors such as nuclear factor kappaB and E2F.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP930077.RAQXdqDcDCINCznM6jqz_BWdeZ9vzRAtDhGSfun8TJn_0130_provenance.
- NP930077.RAQXdqDcDCINCznM6jqz_BWdeZ9vzRAtDhGSfun8TJn_0130_assertion evidence source_evidence_literature NP930077.RAQXdqDcDCINCznM6jqz_BWdeZ9vzRAtDhGSfun8TJn_0130_provenance.
- NP930077.RAQXdqDcDCINCznM6jqz_BWdeZ9vzRAtDhGSfun8TJn_0130_assertion SIO_000772 11711525 NP930077.RAQXdqDcDCINCznM6jqz_BWdeZ9vzRAtDhGSfun8TJn_0130_provenance.
- NP930077.RAQXdqDcDCINCznM6jqz_BWdeZ9vzRAtDhGSfun8TJn_0130_assertion wasDerivedFrom befree-20140225 NP930077.RAQXdqDcDCINCznM6jqz_BWdeZ9vzRAtDhGSfun8TJn_0130_provenance.
- NP930077.RAQXdqDcDCINCznM6jqz_BWdeZ9vzRAtDhGSfun8TJn_0130_assertion wasGeneratedBy ECO_0000203 NP930077.RAQXdqDcDCINCznM6jqz_BWdeZ9vzRAtDhGSfun8TJn_0130_provenance.